Moderna | MRNA - PE Price to Earnings


Moderna reported 27.22 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Amgen 18.07 1.77 Jun/2026
Arrowhead Research 39.19 0 Jun/2026
Biogen 23.23 9.53 Jun/2026
BioMarin Pharmaceutical 21.07 5.79 Jun/2026
Celltrion 58.97 8.86 Mar/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Incyte 14.45 0.9 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Organigram Holdings 12.01 222.99 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 16.35 2.78 Jun/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Qiagen NV 16.72 2.76 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
Sartorius 52.99 9.56 Jun/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
United Therapeutics 19.15 1.27 Jun/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 36.27 11.42 Jun/2026